OAM
EVH icon

Oberweis Asset Management’s Evolent Health EVH Stock Holding History

Oberweis Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-338,940
Closed -$11.1M – 202
2024
Q1 		$11.1M Buy
338,940
+124,400
+58% +$3.97M 0.8% 44
2023
Q4 		$7.09M Sell
214,540
-40,920
-16% -$1.16M 0.66% 42
2023
Q3 		$6.96M Buy
255,460
+27,550
+12% +$766K 0.74% 29
2023
Q2 		$6.91M Buy
227,910
+60,200
+36% +$1.95M 0.84% 21
2023
Q1 		$5.44M Buy
167,710
+28,370
+20% +$897K 0.84% 21
2022
Q4 		$3.91M Buy
139,340
+40,930
+42% +$1.17M 0.83% 23
2022
Q3 		$3.54M Buy
98,410
+20,100
+26% +$708K 0.83% 22
2022
Q2 		$2.4M Buy
78,310
+61,210
+358% +$1.78M 0.61% 30
2022
Q1 		$552K Buy
+17,100
New +$448K 0.11% 108

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Oberweis Asset Management's EVH Position: Q2 2024 in Review

Oberweis Asset Management sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 338,940 shares — an estimated $11.1M sold.

Oberweis Asset Management first reported a position in EVH in Q1 2022 and held it in 9 quarters. The position peaked at $11.1M in Q1 2024. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Oberweis Asset Management reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Oberweis Asset Management sold 338,940 Evolent Health shares in Q2 2024, an estimated $11.1M.
  • Oberweis Asset Management first reported a position in Evolent Health in Q1 2022 and held it in 9 quarters.
  • Oberweis Asset Management's Evolent Health position peaked at $11.1M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Oberweis Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.